Navigation Links
Arete Therapeutics Appoints Donald Santel to Board of Directors
Date:12/6/2007

HAYWARD, Calif., Dec. 6 /PRNewswire/ -- Arete Therapeutics Inc., a privately-held biopharmaceutical company developing first-in-class small molecule therapeutics for the treatment of cardiovascular, inflammatory and metabolic diseases, today announced the appointment of Donald J. Santel to its board of directors.

"We are very pleased to welcome Don to our board of directors, as his strategic and operational insights will be of great benefit to the Company as we advance our first-in-class antihypertensive agent AR9281 toward a clinical proof of concept," said Dinesh V. Patel, Ph.D., president and chief executive officer of Arete Therapeutics.

"Don's broad experience coupled with his understanding of the opportunities and challenges in building innovative healthcare organizations make him a valuable addition to the board of directors," said James Topper, M.D., Ph.D., chairman of the board of Arete Therapeutics.

Donald J. Santel brings more than 25 years experience in the biotechnology/biopharmaceutical and medical device industries. Most recently, he was co-founder and chief executive officer at CoTherix, Inc., where he launched Ventavis(R) Inhalation Solution and led the sale of the company to Actelion Pharmaceuticals, Ltd. in January 2007. Prior to CoTherix, he served as president and chief operating officer of Reflow, and sold the company to Fox Hollow (now EV3) and served as vice president of marketing and international sales at Cardiac Pathways Corporation, a medical device company later acquired by Boston Scientific. Mr. Santel began his career at Medtronic, Inc. Currently, Mr. Santel also serves on the board of Anthera Pharmaceuticals, ChemGenex Pharmaceuticals, and Hyperion Therapeutics. He has a BSE from Purdue University and an MS in from the University of Minnesota.

About Arete Therapeutics Inc.

Arete Therapeutics Inc. is a privately held pharmaceutical Company discovering and developing first-in-class small molecul
'/>"/>

SOURCE Arete Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
2. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
3. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
4. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
5. Prime Therapeutics Receives TIPPS Certification
6. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
7. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
8. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
9. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
10. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
11. Prime Therapeutics Announces URAC Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Board certified otolaryngologist Dr. ... Center . , Dr. Antunes is a fellowship trained facial ... procedures. In addition to performing cosmetic and reconstructive surgery on the face, he ...
(Date:6/30/2015)... ... 2015 , ... The United Nations Foundation’s Universal Access Project, in partnership with ... Care Youth contest today. Why We Care Youth serves as a platform for young ... has personally meant to them, and why U.S. policymakers should care about expanding access ...
(Date:6/30/2015)... ... June 30, 2015 , ... NJ Top Dentist, Dr. ... 13th, she hosted a CPR Course for members of the Bergen County Dental Society. ... updated on the latest CPR recommendations for Healthcare Providers. Life Support from Hackensack ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... testosterone claims alleging heart attack and stroke incidents are linked to testosterone replacement ... The Case Management Conference is scheduled for July 9, 2015, according to court ...
(Date:6/30/2015)... FL (PRWEB) , ... June 30, 2015 , ... ... specializing in affordable addiction care in Florida on June 12th. Holly Vasquez-Cortella ... The Fix - a website dedicated to reporting on trending addiction news and ...
Breaking Medicine News(10 mins):Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 2Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 2Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 4Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 3
... , , ... provider of cardiovascular technologies, announced today at the Transcatheter Cardiovascular ... Food and Drug Administration has cleared the company,s MEGA(TM) ... 50cc IAB with a true 8Fr. shaft, the MEGA has ...
... DETROIT, Sept. 23 Caraco Pharmaceutical Laboratories, Ltd. (NYSE ... Georges Ugeux resigned as a director of the Company and from ... was the chairman of the independent committee. , , ... disagreements with the majority shareholder and senior management of the Company ...
... , NEW YORK, Sept. 23 The Michael ... research to successfully translate neurotrophic factor advances from pre-clinical and ... disease. The funding will be awarded under a new Directed ... , , The Foundation,s intention is ...
... , , , CAMDEN, N.J., Sept. 23 ... a result of a Consent Order agreed to by the parties in ... , In an agreement reached in the United States District ... their methodologies when making claims about top docs. In addition, they agree ...
... all agree, though, that biggest risk factor is the brain ... way to reduce the chances of developing dementia such as ... stroke by concentrating on all the known stroke risk factors, ... from an analysis of 30 previous studies that involved more ...
... City, Utah) University of Utah College of Nursing faculty ... Business Magazine today as one of its 2009 Health ... within the health care,system and contributes to continuously improving ... took place at the Grand America Hotel located in ...
Cached Medicine News:Health News:MAQUET Cardiovascular Receives FDA Clearance for MEGA(TM), the World's First 8Fr. 50cc Intra-Aortic Balloon Catheter 2Health News:MAQUET Cardiovascular Receives FDA Clearance for MEGA(TM), the World's First 8Fr. 50cc Intra-Aortic Balloon Catheter 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors 3Health News:Michael J. Fox Foundation Commits Up to $5 Million to Help Advance Neurotrophic Factors 'From Promise to Reality' As Parkinson's Treatment 2Health News:Virtua's 'Top Docs' Ad Campaign Survives Cooper's Law Suit 2Health News:Preventing Second Stroke May Stave Off Dementia 2Health News:Preventing Second Stroke May Stave Off Dementia 3Health News:U. College of Nursing's Kathie Supiano a 'health care hero' 2
(Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
(Date:6/30/2015)... -- July 4 th is this weekend, a time we ... people behind it. To help honor our current nation,s heroes, ... Medical Card, a leading provider of free pharmacy ... independence for our disabled military veterans, police, firemen, and EMS ... prescriptions. "Due to USA ...
(Date:6/30/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/pggcjf/global_endoscopy ) ... Endoscopy Devices Market 2015-2019" report to their ... to grow at a CAGR of 5.53% over ... market can be segmented into three based on ... market can be further segments in terms of ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 3
... that it will report its 2011 first quarter earnings on Friday, ... host an analyst and investor call at 10:00 AM EDT live ... participate in the conference call within the U.S. and Canada, dial ... dial (708) 290-1340. The conference ID is 74735682. ...
... 14, 2011 Cardinal Health today opened its first ... its nationwide capability to manufacture molecular imaging biomarkers that ... cancer, neurological disorders and heart disease. Cyclotrons ... Tomography (PET) molecular imaging agents, one of the fastest-growing ...
Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: